Skip to main content
Top
Published in: Cancer Causes & Control 1/2014

01-01-2014 | Original paper

Screening for colorectal cancer: using data to set prevention priorities

Authors: Graham A. Colditz, Lucy D’Agostino McGowan, Aimee S. James, Kari Bohlke, Melody S. Goodman

Published in: Cancer Causes & Control | Issue 1/2014

Login to get access

Abstract

Introduction

Adherence to colorectal cancer screening recommendations is known to vary by state, but less information is available about within-state variability. In the current study, we assess county-level screening rates for Missouri, with the goal of better targeting public health efforts to increase screening.

Methods

Prevalence of colorectal cancer screening among Missouri adults between the ages of 50 and 74 was obtained from 2008 and 2010 Behavioral Risk Factor Surveillance System data. We used multilevel logistic regression to generate county-specific estimates. After excluding 77 counties with fewer than 30 respondents, information was available about 3,739 individuals in 37 counties, representing 78.5 % of the state population.

Results

Across counties, the prevalence of being up-to-date with recommended colorectal cancer screening ranged from 25 to 70 %.

Conclusion

State-level information about colorectal cancer screening masks substantial within-state variability. Assessing and monitoring county-level disparities in screening can guide public health efforts to increase screening and reduce colorectal cancer mortality. More complete population survey data will make such analysis possible.
Literature
1.
go back to reference Joseph DA, King JB, Miller JW, Richardson LC (2012) Prevalence of colorectal cancer screening among adults—behavioral risk factor surveillance system, United States, 2010. MMWR Morb Mortal Wkly Rep 61(Suppl):51–56PubMed Joseph DA, King JB, Miller JW, Richardson LC (2012) Prevalence of colorectal cancer screening among adults—behavioral risk factor surveillance system, United States, 2010. MMWR Morb Mortal Wkly Rep 61(Suppl):51–56PubMed
2.
go back to reference Centers for Disease Control and Prevention (2012) Cancer screening—United States, 2010. MMWR Morb Mortal Wkly Rep 61:41–45 Centers for Disease Control and Prevention (2012) Cancer screening—United States, 2010. MMWR Morb Mortal Wkly Rep 61:41–45
3.
go back to reference U.S. Department of Health and Human Services (2010) Healthy people 2020. Promotion OoDPaH (ed). Washington, D.C U.S. Department of Health and Human Services (2010) Healthy people 2020. Promotion OoDPaH (ed). Washington, D.C
4.
go back to reference U S Preventive Services Task Force (2008) Screening for colorectal cancer: U.S. preventive services task force recommendation statement. Ann Intern Med 149:627–637CrossRef U S Preventive Services Task Force (2008) Screening for colorectal cancer: U.S. preventive services task force recommendation statement. Ann Intern Med 149:627–637CrossRef
5.
go back to reference Naishadham D, Lansdorp-Vogelaar I, Siegel R, Cokkinides V, Jemal A (2011) State disparities in colorectal cancer mortality patterns in the United States. Cancer Epidemiol Biomarkers Prev 20:1296–1302PubMedCrossRef Naishadham D, Lansdorp-Vogelaar I, Siegel R, Cokkinides V, Jemal A (2011) State disparities in colorectal cancer mortality patterns in the United States. Cancer Epidemiol Biomarkers Prev 20:1296–1302PubMedCrossRef
6.
go back to reference TE Raghunathan XD, Schenker N, Parsons VL, Davis WW, Dodd KW, Feuer EJ (2007) Combining Information from two surveys to estimate county level prevalence rates of cancer risk factors and screening. J Am Stat Assoc 102:474–486CrossRef TE Raghunathan XD, Schenker N, Parsons VL, Davis WW, Dodd KW, Feuer EJ (2007) Combining Information from two surveys to estimate county level prevalence rates of cancer risk factors and screening. J Am Stat Assoc 102:474–486CrossRef
7.
go back to reference Prevention CfDCa (2013) The guide to community preventive services (The Community Guide), Atlanta (GA) Prevention CfDCa (2013) The guide to community preventive services (The Community Guide), Atlanta (GA)
8.
go back to reference Baron RC, Rimer BK, Coates RJ et al (2008) Client-directed interventions to increase community access to breast, cervical, and colorectal cancer screening a systematic review. Am J Prev Med 35:S56–S66PubMedCrossRef Baron RC, Rimer BK, Coates RJ et al (2008) Client-directed interventions to increase community access to breast, cervical, and colorectal cancer screening a systematic review. Am J Prev Med 35:S56–S66PubMedCrossRef
9.
go back to reference Wei EK, Ryan CT, Dietrich AJ, Colditz GA (2005) Improving colorectal cancer screening by targeting office systems in primary care practices: disseminating research results into clinical practice. Arch Intern Med 165:661–666PubMedCrossRef Wei EK, Ryan CT, Dietrich AJ, Colditz GA (2005) Improving colorectal cancer screening by targeting office systems in primary care practices: disseminating research results into clinical practice. Arch Intern Med 165:661–666PubMedCrossRef
10.
go back to reference Lobb R, Colditz GA (2013) Implementation science and its application to population health. Annu Rev Public Health 34:235–251PubMedCrossRef Lobb R, Colditz GA (2013) Implementation science and its application to population health. Annu Rev Public Health 34:235–251PubMedCrossRef
11.
go back to reference Kania J, Kramer M (2011) Collective impact. Stanf Soc Innov Rev 9:36–41 Kania J, Kramer M (2011) Collective impact. Stanf Soc Innov Rev 9:36–41
12.
go back to reference Colditz GA, Dart H (2013) Massachusetts leads the nation in colorectal cancer screening: what lessons can we learn from Implementing prevention-translating epidemiology to practice? Epidemiology 3:e111 Colditz GA, Dart H (2013) Massachusetts leads the nation in colorectal cancer screening: what lessons can we learn from Implementing prevention-translating epidemiology to practice? Epidemiology 3:e111
13.
go back to reference Joseph DA, DeGroff AS, Hayes NS, Wong FL, Plescia M (2011) The colorectal cancer control program: partnering to increase population level screening. Gastrointest Endosc 73:429–434PubMedCrossRef Joseph DA, DeGroff AS, Hayes NS, Wong FL, Plescia M (2011) The colorectal cancer control program: partnering to increase population level screening. Gastrointest Endosc 73:429–434PubMedCrossRef
14.
go back to reference American Cancer Society (2013) Cancer facts and figures 2013. American Cancer Society, Atlanta American Cancer Society (2013) Cancer facts and figures 2013. American Cancer Society, Atlanta
15.
go back to reference Centers for Disease C, Prevention. (2009) Estimated county-level prevalence of diabetes and obesity—United States, 2007. MMWR Morb Mortal Wkly Rep 58:1259–1263 Centers for Disease C, Prevention. (2009) Estimated county-level prevalence of diabetes and obesity—United States, 2007. MMWR Morb Mortal Wkly Rep 58:1259–1263
16.
go back to reference Joshu CE, Parmigiani G, Colditz GA, Platz EA (2012) Opportunities for the primary prevention of colorectal cancer in the United States. Cancer Preve Res 5:138–145CrossRef Joshu CE, Parmigiani G, Colditz GA, Platz EA (2012) Opportunities for the primary prevention of colorectal cancer in the United States. Cancer Preve Res 5:138–145CrossRef
17.
go back to reference Goodman MS (2010) Comparison of small-area analysis techniques for estimating prevalence by race. Prev Chronic Dis 7:A33PubMedCentralPubMed Goodman MS (2010) Comparison of small-area analysis techniques for estimating prevalence by race. Prev Chronic Dis 7:A33PubMedCentralPubMed
18.
go back to reference Jia H, Muennig P, Borawski E (2004) Comparison of small-area analysis techniques for estimating county-level outcomes. Am J Prev Med 26:453–460PubMedCrossRef Jia H, Muennig P, Borawski E (2004) Comparison of small-area analysis techniques for estimating county-level outcomes. Am J Prev Med 26:453–460PubMedCrossRef
19.
go back to reference Blumberg SJ, Luke JV, Ganesh N, Davern ME, Boudreaux MH, Soderberg K (2011) Wireless substitution: state-level estimates from the National Health Interview Survey, January 2007-June 2010. Natl Health Stat Rep 1–26:8 Blumberg SJ, Luke JV, Ganesh N, Davern ME, Boudreaux MH, Soderberg K (2011) Wireless substitution: state-level estimates from the National Health Interview Survey, January 2007-June 2010. Natl Health Stat Rep 1–26:8
20.
go back to reference Vernon SW, Tiro JA, Vojvodic RW et al (2008) Reliability and validity of a questionnaire to measure colorectal cancer screening behaviors: does mode of survey administration matter? Cancer Epidemiol Biomarkers Prev 17:758–767PubMedCrossRef Vernon SW, Tiro JA, Vojvodic RW et al (2008) Reliability and validity of a questionnaire to measure colorectal cancer screening behaviors: does mode of survey administration matter? Cancer Epidemiol Biomarkers Prev 17:758–767PubMedCrossRef
21.
go back to reference White A, Vernon SW, Eberth JM et al (2013) Correlates of self-reported colorectal cancer screening accuracy in a multi-specialty medical group practice. Open J Epidemiol 3:20–24PubMedCentralPubMedCrossRef White A, Vernon SW, Eberth JM et al (2013) Correlates of self-reported colorectal cancer screening accuracy in a multi-specialty medical group practice. Open J Epidemiol 3:20–24PubMedCentralPubMedCrossRef
Metadata
Title
Screening for colorectal cancer: using data to set prevention priorities
Authors
Graham A. Colditz
Lucy D’Agostino McGowan
Aimee S. James
Kari Bohlke
Melody S. Goodman
Publication date
01-01-2014
Publisher
Springer Netherlands
Published in
Cancer Causes & Control / Issue 1/2014
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-013-0311-0

Other articles of this Issue 1/2014

Cancer Causes & Control 1/2014 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine